Back to Market Feed

Product Information

BREO ELLIPTA 50-25 MCG INHALER is a brand product labeled by GlaxoSmithKline LLC, priced at $6.4829 per EA under NDC 00173091610. Its NADAC has been published 118 times since May 22, 2024.

FDA first approved this application on May 10, 2013.

BREO ELLIPTA 50-25 MCG INHALER

fluticasone furoate and vilanterol trifenatate
$6.4829per EA

Strength

50; 25 ug/1; ug/1

NDC

00173091610

Classification

Brand

Dosage Form

POWDER

Route

RESPIRATORY (INHALATION)

Effective Date

8/19/2026

Approval Type

New Drug (NDA)

FDA Application

NDA204275

FDA Approved

5/10/2013

On Market Since

5/12/2023

Pharmacological Classes

Adrenergic beta2-Agonists
Corticosteroid Hormone Receptor Agonists
Corticosteroid
beta2-Adrenergic Agonist

Price Statistics

The NADAC for BREO ELLIPTA 50-25 MCG INHALER has been published 118 times since May 22, 2024, and over the history we have for it it has held within roughly two percent of its current level. The table below summarizes its recorded NADAC range and movement.

Current price$6.4829 per EA
All-time high$6.5164 (Jun 12, 2024)
All-time low$6.4829 (Aug 19, 2026)
52-week high$6.4931
52-week low$6.4829
Median price$6.4974
Average price$6.4974
Largest weekly change-0.1% (Jun 19, 2024)
Weeks tracked118
Tracking sinceMay 22, 2024

Price History

1W

-0.0%

1M

-0.0%

3M

-0.0%

6M

-0.1%

1Y

-0.2%

3Y

N/A

5Y

N/A

All

-0.5%

Generic Alternatives

No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the fluticasone furoate and vilanterol trifenatate market page.

Lowest-Cost Alternatives

No alternatives available

No alternatives found with the same active ingredient and strength in a comparable dosage form.

Related Drugs

Same classification

PREPARATION H HC 1% CREAM
Brand
00573283010•Haleon US Holdings LLC
$0.2072
per GM
DERMA-SMOOTHE-FS SCALP OIL
Brand
68791010204•Royal Pharmaceuticals
$0.2421
per ML
DERMA-SMOOTHE-FS BODY OIL
Brand
68791010104•Royal Pharmaceuticals
$0.2424
per ML
MEDROL 4 MG TABLET
Brand
00009005602•Pharmacia & Upjohn Company LLC
$0.2454
per EA
MEDROL 4 MG DOSEPAK
Brand
00009005604•Pharmacia & Upjohn Company LLC
$0.2908
per EA
CORTEF 5 MG TABLET
Brand
00009001201•Pharmacia & Upjohn Company LLC
$0.9781
per EA
DERMOTIC OIL 0.01% EAR DROPS
Brand
68791010320•Royal Pharmaceuticals
$1.1236
per ML
NASONEX 24HR ALLERGY 50 MCG NASAL SPRAY
Brand
00113172002•L. Perrigo Company
$1.1926
per ML
CHILD FLONASE ALLER RLF 50 MCG
Brand
00135058202•Haleon US Holdings LLC
$1.2091
per ML
FLONASE ALLERGY RLF 50 MCG SPR
Brand
00135057602•Haleon US Holdings LLC
$1.2148
per ML

Frequently asked questions

What is the NADAC price of BREO ELLIPTA 50-25 MCG INHALER?

The current National Average Drug Acquisition Cost (NADAC) for BREO ELLIPTA 50-25 MCG INHALER, manufactured by GlaxoSmithKline LLC, is $6.4829 per EA (NDC 00173091610), effective Aug 19, 2026.

How has the price of BREO ELLIPTA 50-25 MCG INHALER changed over time?

Over the history we have for it, the NADAC for BREO ELLIPTA 50-25 MCG INHALER has held within roughly two percent of its current level. It has been tracked across 118 weekly CMS publications since May 22, 2024.

What are the highest and lowest recorded NADAC prices for BREO ELLIPTA 50-25 MCG INHALER?

Since May 22, 2024, the NADAC for BREO ELLIPTA 50-25 MCG INHALER has ranged from a low of $6.4829 (Aug 19, 2026) to a high of $6.5164 (Jun 12, 2024), with a median of $6.4974 per EA.

Are there cheaper alternatives to BREO ELLIPTA 50-25 MCG INHALER?

No other NADAC-published product currently shares the active ingredient and strength of BREO ELLIPTA 50-25 MCG INHALER in a comparable dosage form, so no direct lower-cost alternative is listed.

Who manufactures BREO ELLIPTA 50-25 MCG INHALER?

BREO ELLIPTA 50-25 MCG INHALER (NDC 00173091610) is labeled by GlaxoSmithKline LLC, and CMS classifies it as a brand product.